Medical News: New ARB Cleared for Hypertension Treatment – in Cardiovascular, Hypertension from MedPage Today

The FDA has approved azilsartan medoxomil (Edarbi), an oral angiotensin II receptor blocker (ARB) for hypertension, expanding the ranks of ARBs now available to U.S. patients.

TAK-491 would have been a better brand name IMHO.